Internal Medicine, Nephrology · Mission, TX
NPI
1487975439
Since 2010
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
6
Medicare group memberships
Hospitals
3
Hospital affiliations
1904 River Bend Dr
Mission, TX, 78572
Phone (956) 897-0304
Groups this clinician bills Medicare through
Medicare paid, 2024
$289K
2,631 services
Medicare patients, 2024
310
Average age 73
Drug cost, 2024
$3.1M
4,089 prescriptions
Company payments, 2025
$753
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul-Moreau Bossous was code 99233 (hospital e&m - subsequent), 1,754 times for 139 patients. In total Paul-Moreau Bossous billed 2,631 services in 14 codes, and Medicare paid $289K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-09-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 1,754 | 139 | $89.90 | $158K |
| 99214 Office E&M - Established | Office | 328 | 136 | $92.73 | $30K |
| 90960 ESRD Related Services (not dialysis) | Office | 204 | 44 | $260.59 | $53K |
| 99232 Hospital E&M - Subsequent | Facility | 94 | 28 | $59.96 | $5,636 |
| 99223 Hospital E&M - Initial | Facility | 79 | 76 | $131.22 | $10K |
| 99205 Office E&M - New | Office | 71 | 71 | $162.16 | $12K |
| 90961 ESRD Related Services (not dialysis) | Office | 61 | 25 | $222.45 | $14K |
| 90962 ESRD Related Services (not dialysis) | Office | 16 | 11 | $147.53 | $2,361 |
By year: 2022 $292K for 3,007 services; 2023 $303K for 2,513 services; 2024 $289K for 2,631 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paul-Moreau Bossous prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 1,139 prescriptions and refills. In total Paul-Moreau Bossous wrote 4,089 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 1,139 | 2,231 | 374 | $1.2M |
| Lokelma Sodium Zirconium Cyclosilicate | 283 | 585 | 121 | $461K |
| Kerendia Finerenone | 260 | 518 | 92 | $316K |
| Indapamide Generic | 257 | 721 | 105 | $2,633 |
| Torsemide Generic | 142 | 247 | 41 | $2,306 |
| Januvia Sitagliptin Phosphate | 132 | 182 | 33 | $97K |
| Sevelamer Carbonate Generic | 122 | 182 | 45 | $21K |
| Jardiance Empagliflozin | 115 | 231 | 54 | $129K |
| Velphoro Sucroferric Oxyhydroxide | 110 | 112 | 25 | $249K |
| Veltassa Patiromer Calcium Sorbitex | 89 | 161 | 47 | $159K |
| Carvedilol Generic | 88 | 157 | 30 | $309 |
| Amlodipine Besylate Generic | 84 | 193 | 30 | $300 |
| Irbesartan Generic | 71 | 177 | 22 | $1,036 |
| Atorvastatin Calcium Generic | 65 | 143 | 26 | $276 |
| Candesartan Cilexetil Generic | 60 | 104 | 20 | $3,589 |
Brand drugs: 2,328 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul-Moreau Bossous $753 ($753 in general payments such as food, travel and fees) from 7 companies. The largest payer was Fresenius USA Marketing, Inc. with $192.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.